Sentry Data Systems launches Reclaim Rx™ in response to new proposed process imposed by Big Pharma
Our new Foundations Certificate program is a method of training that is interactive and application based—meaning the training provides scenarios to support optimal use of all of Sentry’s tools in a peer setting.
Expect more at the 340B Coalition Virtual Summer Conference
Expect more with Sentry. You may have seen this statement before, but what does it mean? To us, it means going above and beyond the intricacies of 340B to deliver an experience that inspires confidence and trust that you are getting the most…
Sentry Data Systems joins Ryan White Clinics for 340B Access (RWC-340B) in the fight to protect the nation’s most vulnerable patients
Sentry Data Systems, Inc., a leader in automated pharmacy procurement, utilization management and 340B compliance, has signed on as a Champion Level Benefactor with nonprofit organization Ryan White Clinics for 340B Access (RWC-340B). In this…
Agilum Healthcare Intelligence releases daily real-time nationwide data on COVID-19 survival rates by treatment protocols for hospitalized patients – impacting life-saving medication decisions
Agilum’s proprietary real-world longitudinal patient database provides a mechanism to observe trends and outcomes as they happen. The company is able to deliver updates on current and new treatment regimens of COVID-19 patients – providing…
Sentry's Head of Industry Relations published in Pharmacy Times
Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has written a two-part article for Pharmacy Times about transparency in the 340B program. This second part, which has been published in the March issue, discusses the call for…
Covered entities’ role in tackling COVID-19
One big breaking news item in healthcare so far this month has been the cancellation of HIMSS20 due to concerns surrounding COVID-19, which was closely followed by event cancellations from the American Pharmacists Association and the American…
Sentry Data Systems’ Head of Industry Relations earns Fellow of the American College of Healthcare Executives designation
Sentry is proud to announce that Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has successfully passed the American College of Healthcare Executives (ACHE) Board of Governors Exam, earning her the prestigious Fellow of the…
Sentry’s Head of Industry Relations published in Pharmacy Times
Lisa Scholz, PharmD, FACHE, Sentry’s Head of Industry Relations, has written a two-part article for Pharmacy Times about transparency in the 340B program. The first part, which has been published in the January issue, discusses the political,…
Let's talk trans•fair•ency at 340B Winter
Calls for transparency may seem intimidating, but we’re here to help. To us, it simply means sharing your 340B story — both the benefits AND the costs. And while our solutions can connect you with the data, reporting, analysis and expertise…
Sentry’s Head of Industry Relations published via Texas Healthcare Trustees
Lisa Scholz, PharmD., Sentry’s Head of Industry Relations, has published a white paper as part of the Texas Healthcare Trustees’ Governance Thought Leadership Series. The paper, “340B Program Transparency – is it ‘Trans-fair-ency’?”…
